Research Use Only — Not for Human Consumption · Ships subject to availability
KLOW (80mg)
Blends · KLOW

KLOW (80mg)

from $89.00
Purity
≥ 99%
Format
Lyophilized Powder
Status
Featured
Verified Batch Testing

Mechanism of Action

Advanced multi-peptide research blend combining BPC-157, TB-500, and GHK-CU for multi-pathway cellular studies.

Research Vectors

  • Peptide blend
  • Cellular research
  • Multi-pathway
* Fulfillment subject to stock availability
For research purposes only.This compound is intended strictly for in-vitro laboratory research conducted by qualified professionals. It is not a drug, supplement, cosmetic, or food. It is not intended for use in or on humans or animals and has not been evaluated by the FDA for any purpose.
Recovery Blend · 80mg Total

KLOW Blend Protocol Reference Protocol

Four-compound recovery blend. Reconstituted with BAC water. Daily subcutaneous injection.

BAC Water Reconstitution

Dilution volume: Add 3 mL BAC water to the vial.
Quick-Draw Equivalents:
6 Units≈ 0.83-1.0 mg GHK-Cu
10 Units≈ 1.33-1.67 mg GHK-Cu (30 draws/vial)
12 Units= 2.0 mg GHK-Cu / 400 mcg each

Timing & Administration

☀️ Morning

Often preferred for recovery support. Fits into daily routines more easily.

🌙 Night

Some prefer nighttime as recovery processes naturally increase during sleep.

Blend Composition

GHK-Cu
50 mg
BPC-157
10 mg
TB-500
10 mg
KPV
10 mg

At 12 units (full dose), each injection delivers GHK-Cu ~2 mg · BPC-157 ~400 mcg · TB-500 ~400 mcg · KPV ~400 mcg.

Titration Schedule Guide

Full protocol dose = 12 units daily. Rounding down to 10 units gives exactly 30 injections per vial mixed with 3 mL BAC water.
PhaseDoseDraw VolumeProtocol Notes
Week 1≈ 0.83-1.0 mg GHK-Cu5-6 UnitsTolerance testing and adjustment period. Approximately 167-200 mcg of each blend component.
Week 2≈ 1.33-1.67 mg GHK-Cu8-10 UnitsCommon beginner maintenance range. 10 units = 30-injection vial split.
Week 3+= 2.0 mg GHK-Cu10-12 UnitsFull vendor dose: 12 units = 2 mg GHK-Cu / 400 mcg each of BPC-157, TB-500, KPV.

Cycle Protocol

Protocol: 2-3 months on followed by a 1-month break. This aligns with the standard 8-12 week range.

Observed Side Effects

Injection site irritationHeadacheFlushing / skin sensitivityNauseaFatigueAllergic-type reactions
Safety Notice: Stop and seek medical guidance if severe side effects occur.
Open in Reconstitution Calculator